Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High Risk for Vascular Outcomes - ACCELERATE Trial

07/2016

Dr. Steve Nissen discusses the results and clinical implications of the ACCELERATE Trail, presented at ...
read more ↘
0 Comments
Login to view comments. Click here to Login